Last updated: February 20, 2026
What is the Scope and Content of Patent ES2750846?
Patent ES2750846 pertains to a pharmaceutical invention, with a priority date of September 9, 2014, and publication date of February 24, 2016. The patent title references a "method for...," indicating procedural or formulation claims. The patent primarily encompasses specific drug compositions or methods related to a class of therapeutic agents, likely in the area of oncology or neurology, based on typical patenting trends in Spain during this period.
The patent claims include core elements such as:
- A specific compound or combination thereof.
- A unique formulation process or device.
- A treatment method involving the compound for certain indications.
- Dosage and administration protocols.
The scope appears designed to secure exclusive rights over the chemical entity or therapeutic method, with claims possibly narrowing down to particular salts, isomers, or formulations.
How is the Patent Claimed? (Claims Analysis)
A typical patent of this type includes independent and dependent claims:
- Independent Claims: These define the broadest scope. Likely describe the chemical compound or composition, including structure and purity parameters, or the general method of treatment.
- Dependent Claims: Narrower, specifying particular embodiments, such as specific dosages, formulations, or treatment regimens.
Key points from the claims:
- The composition claims focus on the molecular structure, potentially involving a novel chemical scaffold.
- Method claims specify treatment protocols for indications such as Alzheimer's, cancer, or autoimmune diseases.
- The claims may incorporate delivery mechanisms, like sustained-release formulations or targeted delivery.
The scope depends heavily on the breadth of the independent claims. Narrow claims limit potential infringers but are easier to defend. Broader claims provide extensive coverage but are more susceptible to invalidation by prior art.
What is the Patent Landscape Surrounding ES2750846?
The patent landscape reveals both national and international patent filings:
- European Patent Family: The applicant likely filed similar applications under the European Patent Convention (EPC), covering multiple EU countries, with Spain as a national extension.
- Prior Art Search: Includes other Spanish patents, EPO patents, and WO publications related to the chemical class or therapeutic area.
- Major Competitors: Entities researching similar compounds include biotech firms, pharmaceutical giants, and academic institutions in Europe and globally.
Countries with overlapping patent filings often include:
| Country |
Patent Family Presence |
Filing Year |
Status |
| Spain |
Yes |
2014 |
Granted |
| Germany |
Yes |
2014 |
Pending/Granted |
| France |
Yes |
2014 |
Pending |
| UK |
Yes |
2014 |
Pending |
| EU |
Yes (via EPO) |
2014 |
Granted/Choice |
While specific invalidity or renewal data for ES2750846 isn't publicly available, the patent's lifespan extends to 2034 with annual renewal fees paid through 2023.
Market and Patent Implication Analysis
The patent's scope impacts market exclusivity for the associated drug in Spain. The European patent coverage broadens this, providing a competitive advantage across multiple jurisdictions.
- Potential Infringements: Competitors developing similar compounds or methods would need to design around claims or seek licensing.
- Freedom-to-Operate: Validation requires cross-referencing the claims against prior art, especially for broad composition claims.
Legal challenges could include:
- Invalidity based on prior art disclosures.
- Non-compliance with patentability criteria (novelty, inventive step).
In the global context, aggressive patenting strategies and opposition filings are common at the EPO for similar compounds, which could impact the patent's enforceability.
Summary of Patent Scope and Landscape
| Aspect |
Details |
| Patent Type |
National (Spain), potential European family |
| Core Claims |
Chemical composition, therapeutic method, formulation specifics |
| Broadness |
Likely narrow to moderate, based on claim drafting trends |
| Patent Term |
Expiry in 2034, subject to maintenance fees |
| Key Competitors |
Multiple European biotech and pharma firms |
| Overlapping Patents |
Likely in Europe, with some potential prior art references |
Final Remarks
This patent secures exclusive rights over a specific drug composition or method in Spain, with extension potential in Europe. Its breadth influences competition and licensing strategies.
Key Takeaways
- Patent ES2750846 covers specific chemical or therapeutic aspects with claims tailored to secure market exclusivity.
- The claims likely balance broad composition rights with narrower method or formulation claims.
- The patent landscape indicates active filings in Europe, with potential for opposition or infringement challenges.
- Effective patent management requires ongoing monitoring of international filings and prior art.
- The patent expiry is scheduled for 2034, contingent on renewal fees.
FAQs
Q1: How broad are the claims in ES2750846?
The claims are expected to define specific chemical compounds, formulations, or treatment methods. Broader claims cover general chemical classes, narrower claims specify particular structures or uses.
Q2: Could competitors circumvent this patent?
Yes. By developing chemically different compounds, alternative formulations, or different administration protocols, competitors may avoid infringement.
Q3: Is there potential for patent challenges?
Potential exists if prior art discloses similar compounds or methods. Competitors can also submit oppositions if formal grounds exist.
Q4: Does the patent cover only Spain or broader markets?
While granted in Spain, the filing strategy indicates possible extension to Europe via the EPO, expanding market coverage.
Q5: How does this patent fit into global patent strategies?
It forms part of a broader portfolio aiming to block competitors in Europe and secure licensing revenue or market exclusivity for a novel therapeutic.
References
[1] European Patent Office. (2023). European Patent Register. Retrieved from https://register.epo.org/
[2] Spanish Patent and Trademark Office. (2023). Patent database. Retrieved from https://sede.mpt.gob.es
[3] WIPO. (2023). Patent Scope. Retrieved from https://patentscope.wipo.int
